» Articles » PMID: 34224248

A Review of Neuroradiological Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19)

Overview
Journal Neuroradiol J
Publisher Sage Publications
Specialties Neurology
Radiology
Date 2021 Jul 5
PMID 34224248
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection.

Methods: The relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text articles published from 23 January 2020 to 23 February 2021.

Results: In 23 studies the number of patients with SARS-CoV-2 infection was 20,850 and the number of patients with neurological manifestations was 1996 (9.5%). The total number of patients with neuroradiological abnormalities was 602 (2.8%). SARS-CoV-2 has led to various neuroimaging abnormalities which can be categorised by neuroanatomical localisation of lesions and their main probable underlying pathogenesis. Cranial nerve and spinal root abnormalities were cranial neuritis and polyradiculitis. Parenchymal abnormalities fell into four groups of: (a) thrombosis disorders, namely ischaemic stroke and sinus venous thrombosis; (b) endothelial dysfunction and damage disorders manifested as various types of intracranial haemorrhage and posterior reversible encephalopathy syndrome; (c) hypoxia/hypoperfusion disorders of leukoencephalopathy and watershed infarction; and (d) inflammatory disorders encompassing demyelinating disorders, encephalitis, vasculitis-like disorders, vasculopathy and cytotoxic lesions of the corpus callosum. Leptomeninges disorders included meningitis. Ischaemic stroke was the most frequent abnormality in these studies.

Conclusion: The review study suggests that an anatomical approach to the classification of heterogeneous neuroimaging findings in patients with SARS-CoV-2 and neurological manifestations would lend itself well for use by practitioners in diagnosis and treatment planning.

Citing Articles

Diagnostic Models for Differentiating COVID-19-Related Acute Ischemic Stroke Using Machine Learning Methods.

Gul Ates E, Coban G, Karakaya J Diagnostics (Basel). 2025; 14(24.

PMID: 39767163 PMC: 11674536. DOI: 10.3390/diagnostics14242802.


Vertebral artery wall inflammation suspected as the cause of cryptogenic ischemic stroke developing during the recovery period of COVID-19.

Hayashi S, Nishimoto Y, Yanase Y, Okune Y, Matsuoka K, Nishimoto S Neuroradiol J. 2023; 37(3):366-371.

PMID: 37566615 PMC: 11138334. DOI: 10.1177/19714009231193159.


COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research.

Kanuri S, Sirrkay P, Ulucay A Egypt Heart J. 2023; 75(1):36.

PMID: 37120772 PMC: 10149046. DOI: 10.1186/s43044-023-00359-0.


Longitudinal changes in global structural brain connectivity and cognitive performance in former hospitalized COVID-19 survivors: an exploratory study.

Tassignon B, Radwan A, Blommaert J, Stas L, Allard S, De Ridder F Exp Brain Res. 2023; 241(3):727-741.

PMID: 36708380 PMC: 9883830. DOI: 10.1007/s00221-023-06545-5.


Virchow's Triad and the Role of Thrombosis in COVID-Related Stroke.

Gonzalez-Gonzalez F, Ziccardi M, McCauley M Front Physiol. 2021; 12:769254.

PMID: 34858214 PMC: 8631516. DOI: 10.3389/fphys.2021.769254.


References
1.
Somani S, Agnihotri S . Emerging Neurology of COVID-19. Neurohospitalist. 2020; 10(4):281-286. PMC: 7495702. DOI: 10.1177/1941874420936096. View

2.
Pilotto A, Masciocchi S, Volonghi I, Crabbio M, Magni E, De Giuli V . Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study. J Infect Dis. 2020; 223(1):28-37. PMC: 7543535. DOI: 10.1093/infdis/jiaa609. View

3.
Mahammedi A, Saba L, Vagal A, Leali M, Rossi A, Gaskill M . Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study. Radiology. 2020; 297(2):E270-E273. PMC: 7587295. DOI: 10.1148/radiol.2020201933. View

4.
Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon R, Reidy J, Lednicky J . Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020; 92(7):699-702. PMC: 7264598. DOI: 10.1002/jmv.25915. View

5.
Lin E, Lantos J, Strauss S, Phillips C, Campion Jr T, Navi B . Brain Imaging of Patients with COVID-19: Findings at an Academic Institution during the Height of the Outbreak in New York City. AJNR Am J Neuroradiol. 2020; 41(11):2001-2008. PMC: 7658823. DOI: 10.3174/ajnr.A6793. View